Literature DB >> 3110101

The effect of alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on mitogen-induced interleukin 2 production.

T L Bowlin, B J McKown, P S Sunkara.   

Abstract

The objective of the present investigation was to examine the effect of DL-alpha-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, on mitogen-induced interleukin 2 production. Treatment with DFMO reduced nylon wool T cell polyamine levels. In contrast, DFMO treatment enhanced, greater than two-fold, detectable levels of concanavalin A-induced interleukin 2 activity. This observed augmentation was not limited to in vitro DFMO treatment, since oral administration of DFMO to C57BL/6 mice also enhanced concanavalin A-induced interleukin 2 levels in vitro. Treatment with exogenous putrescine reversed the effect of DFMO on interleukin 2 levels. These results suggest that the effect of DFMO on interleukin 2 levels is mediated through polyamines. Therefore, polyamine biosynthesis may play a role in the intracellular regulation of interleukin 2 production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110101     DOI: 10.1016/0162-3109(87)90051-8

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  10 in total

1.  Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis.

Authors:  E Flescher; T L Bowlin; A Ballester; R Houk; N Talal
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

2.  Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction.

Authors:  T L Bowlin; A L Rosenberger; B J McKown
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

3.  Inhibition of calcium signalling in murine splenocytes by polyamines: differential effects on CD4 and CD8 T-cells.

Authors:  T Thomas; U B Gunnia; E J Yurkow; J R Seibold; T J Thomas
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

4.  Beta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation.

Authors:  Y Elitsur; G D Luk
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

5.  Epidermal growth factor regulation of DNA synthesis in human colonic lamina propria lymphocytes.

Authors:  Y Elitsur; A P Majumdar; W A Sakr; G D Luk
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

Review 6.  The mechanisms by which polyamines accelerate tumor spread.

Authors:  Kuniyasu Soda
Journal:  J Exp Clin Cancer Res       Date:  2011-10-11

7.  Metabolic modeling of single Th17 cells reveals regulators of autoimmunity.

Authors:  Allon Wagner; Chao Wang; Johannes Fessler; David DeTomaso; Julian Avila-Pacheco; James Kaminski; Sarah Zaghouani; Elena Christian; Pratiksha Thakore; Brandon Schellhaass; Elliot Akama-Garren; Kerry Pierce; Vasundhara Singh; Noga Ron-Harel; Vivian Paraskevi Douglas; Lloyd Bod; Alexandra Schnell; Daniel Puleston; Raymond A Sobel; Marcia Haigis; Erika L Pearce; Manoocher Soleimani; Clary Clish; Aviv Regev; Vijay K Kuchroo; Nir Yosef
Journal:  Cell       Date:  2021-07-02       Impact factor: 66.850

8.  Polyamine deprivation prevents the development of tumour-induced immune suppression.

Authors:  L Chamaillard; V Catros-Quemener; J G Delcros; J Y Bansard; R Havouis; D Desury; A Commeurec; N Genetet; J P Moulinoux
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer.

Authors:  Naveena B Janakiram; Altaf Mohammed; Taylor Bryant; Yuting Zhang; Misty Brewer; Ashley Duff; Laura Biddick; Anil Singh; Stan Lightfoot; Vernon E Steele; Chinthalapally V Rao
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

Review 10.  The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment.

Authors:  Jiachun Lian; Yanfang Liang; Hailiang Zhang; Minsheng Lan; Ziyu Ye; Bihua Lin; Xianxiu Qiu; Jincheng Zeng
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.